Assaraf YG - Search Results

1

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation.

Ferreira JA, Peixoto A, Neves M, Gaiteiro C, Reis CA, Assaraf YG, Santos LL. Ferreira JA, et al. Among authors: assaraf yg. Drug Resist Updat. 2016 Jan;24:34-54. doi: 10.1016/j.drup.2015.11.003. Epub 2015 Nov 25. Drug Resist Updat. 2016. PMID: 26830314 Review.

2

The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

Assaraf YG. Assaraf YG. Drug Resist Updat. 2006 Aug-Oct;9(4-5):227-46. doi: 10.1016/j.drup.2006.09.001. Epub 2006 Nov 7. Drug Resist Updat. 2006. PMID: 17092765 Review.

3

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Shapira A, Livney YD, Broxterman HJ, Assaraf YG. Shapira A, et al. Among authors: assaraf yg. Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16. Drug Resist Updat. 2011. PMID: 21330184 Review.

4

Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.

Gonen N, Assaraf YG. Gonen N, et al. Among authors: assaraf yg. Drug Resist Updat. 2012 Aug;15(4):183-210. doi: 10.1016/j.drup.2012.07.002. Epub 2012 Aug 23. Drug Resist Updat. 2012. PMID: 22921318 Review.

5

Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest.

Raz S, Sheban D, Gonen N, Stark M, Berman B, Assaraf YG. Raz S, et al. Among authors: assaraf yg. Cell Death Dis. 2014 Feb 20;5(2):e1067. doi: 10.1038/cddis.2014.39. Cell Death Dis. 2014. PMID: 24556682 Free PMC article.

6

The folate receptor as a rational therapeutic target for personalized cancer treatment.

Assaraf YG, Leamon CP, Reddy JA. Assaraf YG, et al. Drug Resist Updat. 2014 Oct-Dec;17(4-6):89-95. doi: 10.1016/j.drup.2014.10.002. Epub 2014 Oct 8. Drug Resist Updat. 2014. PMID: 25457975 Review.

7

Molecular basis of resistance to proteasome inhibitors in hematological malignancies.

Niewerth D, Jansen G, Assaraf YG, Zweegman S, Kaspers GJ, Cloos J. Niewerth D, et al. Among authors: assaraf yg. Drug Resist Updat. 2015 Jan;18:18-35. doi: 10.1016/j.drup.2014.12.001. Epub 2014 Dec 10. Drug Resist Updat. 2015. PMID: 25670156 Review.

8

Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.

Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S. Taylor S, et al. Among authors: assaraf yg. Drug Resist Updat. 2015 Nov;23:69-78. doi: 10.1016/j.drup.2015.08.004. Epub 2015 Aug 22. Drug Resist Updat. 2015. PMID: 26341193 Review.

9

Lysosomes as mediators of drug resistance in cancer.

Zhitomirsky B, Assaraf YG. Zhitomirsky B, et al. Among authors: assaraf yg. Drug Resist Updat. 2016 Jan;24:23-33. doi: 10.1016/j.drup.2015.11.004. Epub 2015 Nov 26. Drug Resist Updat. 2016. PMID: 26830313 Review.

10

Could drugs inhibiting the mevalonate pathway also target cancer stem cells?

Likus W, Siemianowicz K, Bieńk K, Pakuła M, Pathak H, Dutta C, Wang Q, Shojaei S, Assaraf YG, Ghavami S, Cieślar-Pobuda A, Łos MJ. Likus W, et al. Among authors: assaraf yg. Drug Resist Updat. 2016 Mar;25:13-25. doi: 10.1016/j.drup.2016.02.001. Epub 2016 Feb 20. Drug Resist Updat. 2016. PMID: 27155373 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters